Fibroblast Growth Factor 23 is Associated with Subclinical Cerebrovascular Damage: the Northern Manhattan Study (NOMAS)

BACKGROUND AND PURPOSE: Elevated fibroblast growth factor 23 (FGF23) regulates phosphate homeostasis and is linked with mortality, cardiovascular events, and stroke. However, the role of FGF23 as a risk factor for subclinical cerebrovascular damage (SCVD) is unclear. METHODS: We used multivariable l...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Stroke
Main Authors: Wright, Clinton B., Shah, Nirav H., Mendez, Armando J., DeRosa, Janet T., Yoshita, Mitsuhiro, Elkind, Mitchell S. V., Sacco, Ralph L., DeCarli, Charles, Rundek, Tatjana, Silverberg, Shonni, Dong, Chuanhui, Wolf, Myles
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4811730/
https://ncbi.nlm.nih.gov/pubmed/26956260
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/STROKEAHA.115.012379
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados